Receptor for hyaluronan‐mediated motility (<scp>RHAMM</scp>) defines an invasive niche associated with tumor progression and predicts poor outcomes in breast cancer patients
| Image |  |
|---|---|
| Description | scientific article published in 2023 |
| Author/s | |
| Publication date | April 26, 2023 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |